2008Chinese Journal of ArteriosclerosisRequires access

Analysis About the Cost and Effect of Nifedipine,Captopril or Combination of both Treatment in Patients with Essential Hypertension

Xue Shu

Open publisher page 0 citations

Abstract

Aim To analyse the cost and effect of nifedipine, captopril or combined treatment used as anti-essential hypertension therapy programs. Methods This study was a randomised single blind controlled clinical trial conducted in outpatient. The trial randomised 330 patients with mild to moderate hypertension aged 18~70 years were divided into three treatment groups: captopril (50 mg daily) group, nifedipine (40 mg daily) group, and captopril+nifedipine group for a mean follow up of 8 week. Results The effects of captopril group and nifedipine group after 8 week administration had similar result. But there was significant difference in blood pressure between captopril+nifedipine group and captopril or nifedipine group. Conclusion Nifedipine combined with captopril lowers blood pressure sufficiently to achieve therapeutic goal in most patients with hypertension.

About this research paper

What this paper is about

Aim To analyse the cost and effect of nifedipine, captopril or combined treatment used as anti-essential hypertension therapy programs. Methods This study was a randomised single blind controlled clinical trial conducted in outpatient. The trial randomised 330 patients with mild to moderate hypertension aged 18~70 years were divided into three treatment groups: captopril (50 mg daily) group, nifedipine (40 mg daily) group, and captopril+nifedipine group for a mean follow up of 8 week. Results The effects of captopril group and nifedipine group after 8 week administration had similar result. But there was significant difference in blood pressure between captopril+nifedipine group and captopril or nifedipine group. Conclusion Nifedipine combined with captopril lowers blood pressure sufficiently to achieve therapeutic goal in most patients with hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To analyse the cost and effect of nifedipine, captopril or combined treatment used as anti-essential hypertension therapy programs. Methods This study was a randomised single blind controlled clinical trial conducted in outpatient. The trial randomised 330 patients with mild to moderate hypertension aged 18~70 years were divided into three treatment groups: captopril (50 mg daily) group, nifedipine (40 mg daily) group, and captopril+nifedipine group for a mean follow up of 8 week. Results The effects of captopril group and nifedipine group after 8 week administration had similar result. But there was significant difference in blood pressure between captopril+nifedipine group and captopril or nifedipine group. Conclusion Nifedipine combined with captopril lowers blood pressure sufficiently to achieve therapeutic goal in most patients with hypertension.

Key concepts: Captopril, Nifedipine, Medicine, Blood pressure, Essential hypertension, Randomized controlled trial, Anesthesia, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis About the Cost and Effect of Nifedipine,Captopril or Combination of both Treatment in Patients with Essential Hypertension — Research Paper | ScholarLens